© Onda
Unlike single-strain disease, Tenacibaculum encompasses multiple species that impact different regions and host fish in unique ways, making prevention and treatment especially difficult. The bacteria’s ability to cause severe lesions, reduce welfare and drive significant mortality underscores the need for reliable study models and innovative health solutions to protect both fish stocks and industry sustainability.
Onda was the first contract research organisation (CRO) to bring a robust and reliable Tenacibaculum maritimum model to market. With the expansion to include T. dicentrarchi and T. finnmarkense, Onda says that it can now support producers and innovators in geographies where these strains pose major threats, including salmon farming regions across Chile, Norway and Canada.
“These new models light the path forward, turning complexity into clarity in the fight against tenacibaculosis, and mapping the battlefield so our clients can get ahead,” said Dr Fabio Zanuzzo, director of aquatic animal health at Onda, in a press release.
For salmon alone, Tenacibaculum infections are estimated to cost the industry tens of millions of dollars annually, but the development of innovative vaccines, treatments, and management strategies requires access to controlled, reliable study models.
According to Onda, its expanded Tenacibaculum platform provides aquaculture companies, biotech innovators, and feed manufacturers with the tools to evaluate candidate products under conditions that replicate real-world challenges.
“These new models underscore Onda’s commitment to addressing the aquaculture industry’s most urgent health challenges,” added Myrna Gillis, Onda’s CEO. “By equipping our clients with robust research platforms, we help them bring effective solutions to market faster, supporting healthier fish, stronger businesses, and a more sustainable food supply.”
